Refractory Status Epilepticus
9
2
2
3
Key Insights
Highlights
Success Rate
60% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 80/100
22.2%
2 terminated out of 9 trials
60.0%
-26.5% vs benchmark
33%
3 trials in Phase 3/4
0%
0 of 3 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 3 completed trials
Clinical Trials (9)
Efficacy and Safety of Perampanel in the Treatment of Refractory Status Epilepticus
Multicenter Retrospective Study of Isoflurane in Refractory and Super-Refractory Status Epilepticus
Ketamine for the Treatment of Refractory Status Epilepticus
buRst-supprESsion TO Stop Refractory Status Epilepticus Post-cardiac Arrest
Feasibility Study: tDCS for Treatment of Refractory Status Epilepticus
Application of tDCS Stimulation in Controlling Refractory Status Epilepticus
To Evaluate the Efficacy, Safety, and Tolerability of Intravenous Ganaxolone Added to Standard of Care in Refractory Status Epilepticus (RSE)
Refractory Status Epilepticus Treatment: Quality and Efficacy of Coma Induction
Ketogenic Diet for Refractory Status Epilepticus